Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tolerance and preconditioning.

R Rejdak1, K Rejdak, M Sieklucka-Dziuba

  • 12nd Department of Ophthalmology, Medical University, Lublin, Poland.

Polish Journal of Pharmacology
|January 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic management of a kissing nevus of the eyelid].

Die Ophthalmologie·2024
Same author

Surgical excision of eyelid tumors and subsequent ophthalmoplastic reconstruction.

Die Ophthalmologie·2023
Same author

[Surgical excision of eyelid tumors and subsequent ophthalmoplastic reconstruction].

Die Ophthalmologie·2023
Same author

[Uncommon indolent mass in the temporal angle of the right eyelid].

Die Ophthalmologie·2022
Same author

[The role of citicoline in glaucoma].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

Pain incidence in cervical dystonia is determined by the disease phenotype.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2020
Same journal

Abstracts of the 8th Conference on Progress in Etiopathogenesis of Seizures. Lublin, Poland, 21 November 2003.

Polish journal of pharmacology·2005
Same journal

Influence of beta-adrenergic antagonists on tear secretion in children.

Polish journal of pharmacology·2005
Same journal

Intraamygdaloid administration of BIBO 3304 increases water intake and extends anxiolytic effects.

Polish journal of pharmacology·2005
Same journal

Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.

Polish journal of pharmacology·2005
Same journal

Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.

Polish journal of pharmacology·2005
Same journal

Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.

Polish journal of pharmacology·2005
See all related articles

Brain tolerance, a temporary resistance to injury, can be induced by mild insults or specific chemicals. This preconditioning may offer a new prophylactic strategy against severe brain damage.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Brain tolerance is a phenomenon where mild insults transiently protect brain tissue from lethal damage.
  • This protective effect resembles transient ischemic attacks (TIAs) that can precede ischemic stroke.
  • Chemical preconditioning, using substances affecting cellular energy metabolism, also confers protection.

Purpose of the Study:

  • To review the phenomenon of brain tolerance and chemical preconditioning.
  • To explore the potential of pharmacological interventions to enhance brain tolerance.
  • To discuss the clinical implications for preventing serious brain insults.

Main Methods:

  • Review of existing experimental and clinical data on brain tolerance and chemical preconditioning.
  • Discussion of specific substances like NMDA receptor antagonists and 2-deoxyglucose.

Related Experiment Videos

  • Analysis of their role in potentiating protective effects.

    • Main Results:

    • Mild, short-duration insults induce transient brain tolerance.
    • Subtoxic doses of certain chemicals (e.g., 3-nitropropionic acid, erythromycin, 2-deoxyglucose) can evoke tolerance.
    • NMDA receptor antagonists and 2-deoxyglucose enhance protective effects against ischemia.

    Conclusions:

    • Brain tolerance, enhanced by pharmacological agents, shows promise as a prophylactic strategy.
    • Further research is needed to validate these findings in various experimental models.
    • This approach may lead to new treatments for preventing severe brain insults in patients.